NASDAQ:PETV PetVivo (PETV) Stock Forecast, Price & News $1.78 +0.03 (+1.71%) (As of 09/26/2023 ET) Add Compare Share Share Today's Range$1.73▼$1.9350-Day Range$1.72▼$2.4552-Week Range$1.66▼$3.60Volume2,665 shsAverage Volume23,188 shsMarket Capitalization$23.37 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About PetVivo (NASDAQ:PETV) StockPetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.Read More PETV Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PETV Stock News HeadlinesSeptember 26, 2023 | americanbankingnews.comHead-To-Head Review: PetVivo (PETV) & Its PeersSeptember 18, 2023 | americanbankingnews.comCritical Comparison: PetVivo (PETV) versus The CompetitionSeptember 26, 2023 | Micro-Cap Stock Trader (Ad)Unlock the treasure on Mount Olympus with this little-known mining stock.Investor Find Lithium Gold and Crush the Bear Market with 32k Metric TonsAugust 28, 2023 | finance.yahoo.comPetVivo Holdings, Inc. Achieves National Distribution of Spryng to More than 500 Veterinary Clinics in 49 StatesAugust 18, 2023 | finance.yahoo.comNew to The Street Announces its Televised Five Corporate Interviews Airing on Newsmax and The FOX Business Network, Episodes 503 and 504; Broadcastings Begin Saturday, August 19, 2023, at 3:30 PM ETAugust 17, 2023 | seekingalpha.comPetVivo receives patent allowance notice from US Patent and Trademark OfficeAugust 17, 2023 | finance.yahoo.comPetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent ApplicationAugust 12, 2023 | finance.yahoo.comPetVivo Holdings, Inc. (NASDAQ:PETV) Q1 2024 Earnings Call TranscriptSeptember 26, 2023 | Micro-Cap Stock Trader (Ad)U.S. drive to onshore battery supply chains could create big winners in lithiumInvestor Find Lithium Gold and Crush the Bear Market with 32k Metric TonsAugust 11, 2023 | msn.comPetVivo Holdings GAAP EPS of -$0.25, revenue of $0.12MJuly 20, 2023 | finance.yahoo.comPetVivo Holdings, Inc. Achieves National Distribution of Spryng to More than 450 Veterinary ClinicsJune 30, 2023 | ca.finance.yahoo.comPETV - PetVivo Holdings, Inc.June 29, 2023 | benzinga.comPetVivo Reports FY23 Full Year Financial Results; FY23 EPS $(0.85) Vs $(0.57) YoY; Revenue $917,162 Vs $115,586 YoYJune 29, 2023 | marketwatch.comPetVivo Has Enough Capital to Operate Until JulyJune 29, 2023 | finance.yahoo.comPETVIVO HOLDINGS, INC. ANNOUNCES RESCHEDULED EARNINGS CALL FOR THE YEAR ENDED MARCH 31, 2023June 27, 2023 | finance.yahoo.comDr. Jeremy Caplin Joins PetVivo Holdings, Inc. as the Director of ResearchJune 21, 2023 | marketwatch.comPetVivo Shares Rise 17% After Initial Regulatory Approval of Biomatrix Human ProductsJune 5, 2023 | finance.yahoo.comDr. Thomas Yarbrough Joins PetVivo Holdings, Inc. as the Senior Research DirectorJune 1, 2023 | finance.yahoo.comDr. Maureen Dower Joins PetVivo Holdings, Inc. as a Senior Technical Services VeterinarianMay 17, 2023 | finance.yahoo.comTrina Lally Joins PetVivo Holdings, Inc. as the Northeast Business Development ManagerApril 24, 2023 | finance.yahoo.comPETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN CHARLESTON, SOUTH CAROLINAMarch 27, 2023 | finance.yahoo.comPETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN ATLANTA, GEORGIAFebruary 13, 2023 | finance.yahoo.comPetVivo Holdings, Inc. (NASDAQ:PETV) Q3 2023 Earnings Call TranscriptFebruary 10, 2023 | finanznachrichten.dePetVivo Holdings, Inc.: PetVivo Reports Third Quarter of Fiscal 2023 Financial ResultsFebruary 2, 2023 | finance.yahoo.comPETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2022January 30, 2023 | finance.yahoo.comPETVIVO HOLDINGS, INC. TO EXHIBIT AT THE MINNESOTA VETERINARY MEDICAL ASSOCIATION ANNUAL MEETING IN MINNEAPOLIS, MINNESOTAJanuary 18, 2023 | proactiveinvestors.comPetVivo CEO "getting great responses" to lead productSee More Headlines Receive PETV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PetVivo and its competitors with MarketBeat's FREE daily newsletter. Email Address PETV Company Calendar Last Earnings8/10/2023Today9/26/2023Next Earnings (Estimated)11/09/2023Fiscal Year End3/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:PETV CUSIPN/A CIK1512922 Webwww.petvivo.com Phone952-405-6216FaxN/AEmployees25Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.90) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,720,000.00 Net Margins-988.42% Pretax Margin-988.42% Return on Equity-863.27% Return on Assets-317.41% Debt Debt-to-Equity Ratio0.05 Current Ratio0.69 Quick Ratio0.42 Sales & Book Value Annual Sales$920,000.00 Price / Sales27.54 Cash FlowN/A Price / Cash FlowN/A Book Value$0.07 per share Price / Book27.57Miscellaneous Outstanding Shares13,130,000Free Float9,858,000Market Cap$25.34 million OptionableNot Optionable Beta1.99 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. John Lai (Age 61)CEO, Pres & Director Comp: $312.65kMr. Robert J. Folkes (Age 60)Chief Financial Officer Comp: $273.07kMr. Randall A. Meyer (Age 59)Chief Operating Officer Comp: $245.41kMr. Randy WentholdChief Science OfficerMr. John F. Dolan (Age 58)Gen. Counsel, Chief Bus. Devel. Officer & Sec. Mr. Gary DeMel (Age 66)Exec. VP of Bus. Devel. Mr. Russell SiakelDirector of MarketingMr. Mark MiddletonNational Director of SalesMore ExecutivesKey CompetitorsNeuroOne Medical TechnologiesNASDAQ:NMTCModular MedicalNASDAQ:MODDAcutus MedicalNASDAQ:AFIBSTRATA Skin SciencesNASDAQ:SSKNSpectral AINASDAQ:MDAIView All CompetitorsInsidersJames Rudolph MartinBought 22,224 shares on 8/21/2023Total: $50,892.96 ($2.29/share)Robert J CostantinoBought 3,350 shares on 3/15/2023Total: $10,117.00 ($3.02/share)Joseph William JasperBought 2,000 shares on 3/13/2023Total: $6,200.00 ($3.10/share)Joseph William JasperBought 500 shares on 3/1/2023Total: $1,470.00 ($2.94/share)Joseph William JasperBought 1,399 shares on 2/27/2023Total: $4,155.03 ($2.97/share)View All Insider Transactions PETV Stock - Frequently Asked Questions How have PETV shares performed in 2023? PetVivo's stock was trading at $1.9599 at the beginning of the year. Since then, PETV stock has decreased by 1.5% and is now trading at $1.9299. View the best growth stocks for 2023 here. When is PetVivo's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023. View our PETV earnings forecast. How were PetVivo's earnings last quarter? PetVivo Holdings, Inc. (NASDAQ:PETV) posted its earnings results on Thursday, August, 10th. The company reported ($0.25) earnings per share (EPS) for the quarter. The firm had revenue of $0.12 million for the quarter. PetVivo had a negative trailing twelve-month return on equity of 863.27% and a negative net margin of 988.42%. What is PetVivo's stock symbol? PetVivo trades on the NASDAQ under the ticker symbol "PETV." How do I buy shares of PetVivo? Shares of PETV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is PetVivo's stock price today? One share of PETV stock can currently be purchased for approximately $1.93. How much money does PetVivo make? PetVivo (NASDAQ:PETV) has a market capitalization of $25.34 million and generates $920,000.00 in revenue each year. The company earns $-8,720,000.00 in net income (profit) each year or ($0.90) on an earnings per share basis. How can I contact PetVivo? PetVivo's mailing address is 5251 Edina Industrial Boulevard, Suite 575 Edina, Minneapolis, MN 55439, United States. The official website for the company is www.petvivo.com. The company can be reached via phone at 952-405-6216 or via email at investors@petvivo.com. This page (NASDAQ:PETV) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PetVivo Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.